Search results
Showing results for
Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.
Willem Kuyken
PhD, DClinPsy Willem Kuyken - Ritblat Professor of Mindfulness and Psychological Science
Francesca Zecchinato
PhD Francesca Zecchinato - Postdoctoral Researcher
Gulamabbas Lakha
MA, PGDip, MSc, MPhil, DPhil, CFA Gulamabbas Lakha - Honorary Research Fellow
Tarek Zghoul
BSc (Hons), MBChB (Hons), MSc, PhD, MRCPsych Tarek Zghoul - Clinical Research Fellow
Mohammed Lashkri
MBChB, MSc, PGCert Mohammed Lashkri - Psychiatrist & Clinical Researcher
Judit Simon
MD (Hons), BA, BSc, MSc, DPhil (Oxford), FFPH Judit Simon - Visiting Professor of Cognitive Health Economics
Rebecca Murphy
DClinPsych Rebecca Murphy - Senior Research Clinician and Hon Clinical Psychologist
Verena Hinze
DPhil Verena Hinze - Senior Postdoctoral Research Fellow
Mina Fazel
DM FRCPsych Mina Fazel - Professor (Chair) of Child & Adolescent Psychiatry
Seena Fazel
BSc (Hons), MBChB, MD, FRCPsych Seena Fazel - Professor of Forensic Psychiatry
Thrisha Krishnakumar
BSc., MSc Thrisha Krishnakumar - Research Assistant in Participatory and Qualitative Methods
